{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05930561",
            "orgStudyIdInfo": {
                "id": "4D-150-C002"
            },
            "organization": {
                "fullName": "4D Molecular Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "4D-150 in Patients With Diabetic Macular Edema",
            "officialTitle": "A Phase 2 Randomized, Active-Controlled, Double-masked Trial of Intravitreal 4D-150 Gene Therapy in Adults With Diabetic Macular Edema (SPECTRA)",
            "therapeuticArea": [
                "Other",
                "Ophthalmology"
            ],
            "study": "in-patients-with-diabetic-macular-edema"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-02-29",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-07-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-26",
            "studyFirstSubmitQcDate": "2023-06-26",
            "studyFirstPostDateStruct": {
                "date": "2023-07-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-09",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "4D Molecular Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).",
            "detailedDescription": "This Phase 2 trial is a prospective, multicenter, randomized, active-controlled, double-masked dose-ranging trial to evaluate the safety and efficacy of 4D-150 in adults with DME. The trial will be conducted in two parts: Dose Confirmation and Dose Expansion."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetic Macular Edema",
                "Diabetic Retinopathy"
            ],
            "keywords": [
                "Retinal gene therapy",
                "Intravitreal gene therapy",
                "DME",
                "SPECTRA"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "In Dose Confirmation (Part 1), subjects (n=12-18) will be sequentially assigned to one of two open-label dose levels of 4D-150 (n=6-9 per dose level). In Dose Expansion (Part 2), subjects (n=54) will be randomized to receive one of two dose levels of 4D-150 (n=18 per dose level) based on results from Dose Confirmation, or aflibercept control (n=18). Subjects will be masked to treatment arm in Dose Expansion (Part 2).",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "No masking in Dose Confirmation (Part 1). In Dose Expansion (Part 2), participants and outcomes assessors will be masked to treatment arm for the duration of the trial.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "4D-150 Part 1 Dose Confirmation Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.",
                    "interventionNames": [
                        "Biological: 4D-150 IVT"
                    ]
                },
                {
                    "label": "4D-150 Part 1 Dose Confirmation Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.",
                    "interventionNames": [
                        "Biological: 4D-150 IVT"
                    ]
                },
                {
                    "label": "4D-150 Part 2 Dose Expansion Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.",
                    "interventionNames": [
                        "Biological: 4D-150 IVT"
                    ]
                },
                {
                    "label": "4D-150 Part 2 Dose Expansion Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1.",
                    "interventionNames": [
                        "Biological: 4D-150 IVT"
                    ]
                },
                {
                    "label": "4D-150 Part 2 Dose Expansion Control",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Aflibercept at a fixed regimen will be administered.",
                    "interventionNames": [
                        "Biological: Aflibercept IVT"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "4D-150 IVT",
                    "description": "4D-150: AAV-based gene therapy comprised of miRNA targeting VEGF-C and codon-optimized sequence encoding aflibercept.",
                    "armGroupLabels": [
                        "4D-150 Part 1 Dose Confirmation Dose Level 1",
                        "4D-150 Part 1 Dose Confirmation Dose Level 2",
                        "4D-150 Part 2 Dose Expansion Dose Level 1",
                        "4D-150 Part 2 Dose Expansion Dose Level 2"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Aflibercept IVT",
                    "description": "Commercially available Active Comparator",
                    "armGroupLabels": [
                        "4D-150 Part 2 Dose Expansion Control"
                    ],
                    "otherNames": [
                        "Eylea"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Annualized number of aflibercept injections in the study eye",
                    "timeFrame": "52 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean cumulative number of aflibercept injections over time",
                    "timeFrame": "52 weeks"
                },
                {
                    "measure": "Change from baseline in BCVA as assessed using the ETDRS Visual Acuity Chart",
                    "timeFrame": "104 weeks"
                },
                {
                    "measure": "Change from baseline in CST measured by spectral domain optical coherence tomography (SD-OCT)",
                    "timeFrame": "104 weeks"
                },
                {
                    "measure": "Percentage of subjects with a \u22652 and \u22653-Step Diabetic Retinopathy Severity (DRS) improvement from baseline on the ETDRS-DRSS",
                    "timeFrame": "104 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Incidence and severity of treatment-emergent adverse events and serious adverse events, including clinically significant changes in safety parameters",
                    "timeFrame": "104 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* \u226518 years of age\n* Type I or Type II diabetes mellitus with macular thickening secondary to DME involving the center of the fovea; diagnosis of DME must be within 2 years of Screening\n* Demonstrate clinical response to on-study aflibercept injection in the study eye.\n* Decreased visual acuity attributable primarily to DME\n* BCVA in the study eye between 25 and 83 ETDRS letters, inclusive (\\~20/320 and 20/25, respectively) at Screening\n* Study eye amenable to IVT injection\n* Sufficient clear ocular media, pupil dilation and fixation in the study eye to permit adequate imaging; ability to perform tests of visual and retinal function and structure; and ability to comply with other protocol-specified procedures\n* Provide written informed consent\n\nExclusion Criteria:\n\n* Macular edema in the study eye considered to be secondary to a cause other than DME\n* Systemic anti-VEGF treatment (e.g. sunitinib, bevacizumab, pazopanib) within 6 months, or anticipated need for systemic anti-VEGF therapy during study participation\n* Systemic corticosteroids (oral, intravenous, intramuscular, intra-articular) or other immunosuppressive medications within 3 months\n* Received an investigational drug, agent, device, or therapy (ocular or non-ocular) in the 3 months (or at least 5 half-lives, whichever is longer) prior to 4D-150 administration (Day 1)\n* Prior gene therapy (ocular or non-ocular) and/or ocular stem cell therapy in either eye\n* Any concurrent ocular condition in the study eye that is likely to require surgical intervention (e.g. cataract surgery) during the 2 year (104 week) study duration\n\nNote: Other inclusion/exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "4DMT Patient Advocacy",
                    "role": "CONTACT",
                    "phone": "(888) 748-8881",
                    "email": "clinicaltrials@4DMT.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Schonmei Lee, MD",
                    "affiliation": "4D Molecular Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Retinal Research Institute LLC",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85053",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michelle Zunitch",
                            "role": "CONTACT",
                            "email": "Mixhelle.Zunitch@researchavp.com"
                        },
                        {
                            "name": "Mark Barakat, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Retina Consultants of Southern Colorado",
                    "status": "RECRUITING",
                    "city": "Colorado Springs",
                    "state": "Colorado",
                    "zip": "80909",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kari Winger",
                            "role": "CONTACT",
                            "email": "Kwinger@coloradoretina.com"
                        },
                        {
                            "name": "Stanford Taylor, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.83388,
                        "lon": -104.82136
                    }
                },
                {
                    "facility": "National Ophthalmic Research Institute",
                    "status": "RECRUITING",
                    "city": "Fort Myers",
                    "state": "Florida",
                    "zip": "33912",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lee Toleman",
                            "role": "CONTACT",
                            "email": "leet@eye.md"
                        },
                        {
                            "name": "Katrina Mears, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.62168,
                        "lon": -81.84059
                    }
                },
                {
                    "facility": "Retina Specialty Institute",
                    "status": "RECRUITING",
                    "city": "Pensacola",
                    "state": "Florida",
                    "zip": "32503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Veronica Wilder",
                            "role": "CONTACT",
                            "email": "VWilder@retinaspecialty.com"
                        },
                        {
                            "name": "Sunil Gupta, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.42131,
                        "lon": -87.21691
                    }
                },
                {
                    "facility": "Retina Vitreous Associates of FL",
                    "status": "RECRUITING",
                    "city": "Saint Petersburg",
                    "state": "Florida",
                    "zip": "33711",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Allison Calvanese",
                            "role": "CONTACT",
                            "email": "ACalvanese@rvaf.com"
                        },
                        {
                            "name": "David EIchenbaum, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.77086,
                        "lon": -82.67927
                    }
                },
                {
                    "facility": "Raj K Maturi MD PC",
                    "status": "RECRUITING",
                    "city": "Carmel",
                    "state": "Indiana",
                    "zip": "46290",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lorraine White",
                            "role": "CONTACT",
                            "email": "Lorrainew@midwesteye.com"
                        },
                        {
                            "name": "Raj Maturi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.97837,
                        "lon": -86.11804
                    }
                },
                {
                    "facility": "Cumberland Valley Retina Consultants",
                    "status": "RECRUITING",
                    "city": "Hagerstown",
                    "state": "Maryland",
                    "zip": "21740",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Erica Buls",
                            "role": "CONTACT",
                            "email": "ericab@retinacare.net"
                        },
                        {
                            "name": "Allen Hu, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.64176,
                        "lon": -77.71999
                    }
                },
                {
                    "facility": "Sierra Eye Associates",
                    "status": "RECRUITING",
                    "city": "Reno",
                    "state": "Nevada",
                    "zip": "89502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lindsey Godoy",
                            "role": "CONTACT",
                            "email": "LGodoy@midwesteye.com"
                        },
                        {
                            "name": "Arshad Khanani, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.52963,
                        "lon": -119.8138
                    }
                },
                {
                    "facility": "Vision Research Center Eye Associates of New Mexico",
                    "status": "RECRUITING",
                    "city": "Albuquerque",
                    "state": "New Mexico",
                    "zip": "87109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Darlene Harbour",
                            "role": "CONTACT",
                            "email": "EDHarbour@eyenm.com"
                        },
                        {
                            "name": "John Pitcher III, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.08449,
                        "lon": -106.65114
                    }
                },
                {
                    "facility": "Western Carolina Retinal Associates",
                    "status": "RECRUITING",
                    "city": "Asheville",
                    "state": "North Carolina",
                    "zip": "28803",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lea Raymer",
                            "role": "CONTACT",
                            "email": "ldoll@aea1961.com"
                        },
                        {
                            "name": "Cameron Stone, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.60095,
                        "lon": -82.55402
                    }
                },
                {
                    "facility": "Verum Research, LLC",
                    "status": "RECRUITING",
                    "city": "Eugene",
                    "state": "Oregon",
                    "zip": "97401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ryan Lieben",
                            "role": "CONTACT",
                            "email": "rlebien@verumresearch.com"
                        },
                        {
                            "name": "Albert Edwards, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.05207,
                        "lon": -123.08675
                    }
                },
                {
                    "facility": "Erie Retina Research",
                    "status": "RECRUITING",
                    "city": "Erie",
                    "state": "Pennsylvania",
                    "zip": "16507",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Beth Hess",
                            "role": "CONTACT",
                            "email": "ehess@erieretinaresearch.com"
                        },
                        {
                            "name": "David Almeida, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.12922,
                        "lon": -80.08506
                    }
                },
                {
                    "facility": "Austin Clinical Research",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78750",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ivana Gunderson",
                            "role": "CONTACT",
                            "email": "igunderson@austinclinicalresearch.com"
                        },
                        {
                            "name": "Brian Berger, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Piedmont Eye Center",
                    "status": "RECRUITING",
                    "city": "Lynchburg",
                    "state": "Virginia",
                    "zip": "24502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Susan Shelton",
                            "role": "CONTACT",
                            "email": "sshelton@piedmonteye.com"
                        },
                        {
                            "name": "Golnaz Javey, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.41375,
                        "lon": -79.14225
                    }
                },
                {
                    "facility": "Emanuelli Research and Development Center",
                    "status": "RECRUITING",
                    "city": "Arecibo",
                    "zip": "X00612",
                    "country": "Puerto Rico",
                    "contacts": [
                        {
                            "name": "Diane Perez",
                            "role": "CONTACT",
                            "email": "dperez@erdpr.com"
                        },
                        {
                            "name": "Andres Emanuelli, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 18.47245,
                        "lon": -66.71573
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008269",
                    "term": "Macular Edema"
                },
                {
                    "id": "D000003930",
                    "term": "Diabetic Retinopathy"
                },
                {
                    "id": "D000004487",
                    "term": "Edema"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008268",
                    "term": "Macular Degeneration"
                },
                {
                    "id": "D000012162",
                    "term": "Retinal Degeneration"
                },
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000003925",
                    "term": "Diabetic Angiopathies"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7657",
                    "name": "Edema",
                    "asFound": "Edema",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11261",
                    "name": "Macular Edema",
                    "asFound": "Macular Edema",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7125",
                    "name": "Diabetic Retinopathy",
                    "asFound": "Diabetic Retinopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11260",
                    "name": "Macular Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M14997",
                    "name": "Retinal Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7120",
                    "name": "Diabetic Angiopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000533178",
                    "term": "Aflibercept"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M257727",
                    "name": "Aflibercept",
                    "asFound": "DNA",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}